Clinical research progress on paclitaxel in the treatment of advanced esophageal cancer

LI Shi-wei,JI Chu-shu,HE Yi-fu

DOI: https://doi.org/10.3969/j.issn.1009-6469.2012.11.001

2012-01-01

Abstract:Due to the high incidence and mortality of digestive system malignant tumor,it is of great significance to make further research for digestive tract tumor.The majority of patients having poor diagnosis is local advanced or distant metastasis esophageal cancer while initial visit,Metastatic esophageal carcinoma is an incurable disease and has poor prognosis,due to the lack of effective therapies to manage this disease.Identifying an optimal dose and schedule for paclitaxel therapy is key to minimizing toxicity while maintaining anti-tumor activity.